Fracture risk in men with congestive heart failure risk reduction with spironolactone. - Wikidata - awgldk - TriplyDB

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

http://www.wikidata.org/entity/Q34791921

about

Hip fractures and heart failure: findings from the Cardiovascular Health Study.Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.1,25-Dihydroxyvitamin D to PTH(1-84) Ratios Strongly Predict Cardiovascular Death in Heart Failure.Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.The renin-angiotensin-aldosterone system and calcium-regulatory hormones Geriatric conditions in heart failure.Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia.Gene Expression Profiles of Peripheral Blood Mononuclear Cells Reveal Transcriptional Signatures as Novel Biomarkers for Cardiac Remodeling in Rats with Aldosteronism and Hypertensive Heart Disease.Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.Coronary computed tomography angiography versus stress testing in suspected coronary disease.Stressor states and the cation crossroads.Parathyroid hormone, a crucial mediator of pathologic cardiac remodeling in aldosteronism.Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study.Risk factors for osteoporotic fractures in persons with spinal cord injuries and disorders.Exercise capacity independently predicts bone mineral density and proximal femoral geometry in patients with acute decompensated heart failure.Congestive heart failure: where homeostasis begets dyshomeostasis.Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage?Clinical fractures among older men with diabetes are mediated by diabetic complications.Actions of pituitary hormones beyond traditional targets.Bone mineral density and vitamin D in PCOS and hirsutism

P2860

Q33568103-E4ACCB87-EBE1-4B2D-9537-1807A7A18B0B Q34008136-54619E06-1B0D-426C-9CBC-E21036B9CA1E Q34061092-61B890CC-0A48-400D-BD9A-83BA25C5E2D1 Q34402961-EC58E64F-347C-4622-A18A-00BE54D2221A Q35055052-9CCC99FE-E238-4F1D-98C8-74F4015F0596 Q35138063-E7E57703-D8CD-4F7C-8AD7-075B47361457 Q35500640-2C69B7EE-E367-4E46-A33C-CFE9D1D413CE Q35755817-C792D8A8-3F05-49CA-9711-738775B3041A Q36114162-67573844-AD2C-4CA2-BF4F-C942A6C30D2E Q36448508-C2A209BD-C48E-4D37-A18C-BE0531D576DE Q36597950-4D2847D0-2113-43DC-A26E-641FB2C58CD3 Q36626405-84CBD8F0-842B-4222-8F04-90CBBFC46191 Q37127338-6BF66A18-C84C-442F-AEAD-2B77CFA9109F Q37319607-7DE27FD0-C875-4E98-8DCF-BADC7E967752 Q37451582-FBFBB556-2CED-4D3B-9C5B-A6B8FC74EAFC Q37502129-29C6039B-DDC7-48BC-8A07-F52D8D1A4AB6 Q37821915-B8D84272-88FD-49BE-9C9B-F418A78DCABA Q37890176-1ECA118C-A380-4C37-B1E8-E3A28FBC8358 Q37988979-6FBF5BBE-2CE1-4DAB-8DB8-27C07E8B0626 Q40468653-C3513545-C940-4F4D-96B1-962C678FE0FE Q40733560-4B937DC2-D4A0-4249-8EC9-DE67CA8E7D80 Q41745822-156FAB69-BBF8-4FD1-B860-7E53FEA4D502 Q42425309-2BB3AB58-3E6C-4E22-90F4-8380EBFE5531 Q44642659-D0ADE21E-4704-49EC-A11F-F0F9E8902A6C Q45071815-95D4CA11-15B7-4911-A1A4-A3D419C752D6 Q52647974-E37A593B-EA0E-43BF-9A4A-5C8754520155 Q59315870-AF8A00DA-D819-44B3-9F8B-45F5265FAA36

P2860

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

http://www.wikidata.org/entity/Q34791921

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@ast

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@en

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@nl

type

label

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@ast

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@en

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@nl

prefLabel

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@ast

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@en

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@nl

P1433

Q34791921-6F0A4AD9-D539-4D1F-A746-6814E2ED7978

P1476

Q34791921-9BE4FDA6-6E27-4DD7-9B46-36CC2FFE1C94

P2093

Q34791921-05730432-4422-45AB-BED5-6F28CD6BB82D

Q34791921-14088163-18EF-4B4B-9B5C-C149645A5E57

Q34791921-19FF4681-BA55-4C9D-83E8-F9F866829843

Q34791921-1BC86FE3-02F6-41E0-819F-319331634055

Q34791921-20836B21-6271-4EAB-A704-6D2F547AFFA2

Q34791921-255E09FB-D032-403F-9066-FF2291D313DE

Q34791921-32ADDBB0-0922-46EA-B915-D87114E1842B

Q34791921-3453ACA2-D1FB-4359-9490-9449B7EB56C5

Q34791921-34A28616-85A1-4C57-BE48-62C338013F07

Q34791921-3D1ACC65-19EA-4473-97ED-464A85F893E2

P304

Q34791921-A4BF456A-B390-4817-B855-516CD6FBDA63

P31

Q34791921-FE8CA699-37BA-4DB0-90FA-EAD1C93D971D

P356

Q34791921-6AE4F6F0-C833-409D-AC86-BC052863ABC4

P407

Q34791921-E2B593C9-E5CE-4BCA-B49C-D70F1CE20080

P433

Q34791921-103E3A98-B520-4486-A7FB-9777E9ECB9BD

P478

Q34791921-CECC2868-DA27-4819-AA26-D02742B51660

P577

Q34791921-B060F27F-A069-4C96-B223-DF6A8218F96B

P5875

Q34791921-B0C8CB26-C851-4CD6-9FC3-23FABCBDE708

P698

Q34791921-3EDB84AF-2672-4D66-B3D6-021CF77D413C

P921

Q34791921-B7C51089-2DDA-4955-B2FE-577043027BCE

P356

J.JACC.2008.03.039

P1433

Journal of the American College of Cardiology

P1476

Fracture risk in men with congestive heart failure risk reduction with spironolactone.

@en

P2093

Andrew J Bush

http://www.w3.org/2001/XMLSchema#string

Ashley R Haskin

http://www.w3.org/2001/XMLSchema#string

Bilal Q Khan

http://www.w3.org/2001/XMLSchema#string

Catherine R Womack

http://www.w3.org/2001/XMLSchema#string

Dwight A Dishmon

http://www.w3.org/2001/XMLSchema#string

Jessica D Cross

http://www.w3.org/2001/XMLSchema#string

Joseph P Nesheiwat

http://www.w3.org/2001/XMLSchema#string

Karl T Weber

http://www.w3.org/2001/XMLSchema#string

Khurram Ahmad

http://www.w3.org/2001/XMLSchema#string

Laura D Carbone

http://www.w3.org/2001/XMLSchema#string

P304

135-138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2008.03.039

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5254282

http://www.w3.org/2001/XMLSchema#string

P698

18598893

http://www.w3.org/2001/XMLSchema#string

P921